Skip to content
Open access

ClinGen Bayesian Framework-Based Interpretation and Functional Validation of a COL10A1 Missense Variant in a Patient With Skeletal Dysplasia.

Nov 2026 · Annals of Laboratory Medicine · 0 citations
Medicine

Abstract

Rare missense variants are difficult to interpret when phenotypes overlap and evidence is incomplete. We demonstrated the practical application of the ClinGen Bayesian framework for the interpretation of a COL10A1 missense variant identified in a Korean family with short stature across four generations. A 38-yr-old woman with lifelong short stature, coxa vara, hip pain, and previous suspicion of achondroplasia underwent clinical exome sequencing. A heterozygous variant [NM_000493.4:c.1930C>T, p.(Leu644Phe)] located in the NC1 domain of COL10A1 was consequently identified. The variant was absent from the general population database (PM2_Supporting, +1) and affected a highly conserved residue. Calibrated in silico tools produced PP3 scores ranging from 0 to +3. The same variant was detected in the proband's mother and younger brother, supporting co-segregation with the familial short-stature phenotype (PP1_Moderate, +2), and structural assessment predicted local destabilization. In zebrafish, mutant col10a1a mRNA overexpression reduced head size and narrowed jaw-related cartilages, supporting PS3_Moderate (+2). After incorporation of a recent external de novo occurrence (PS2_Supporting, +1), the combined evidence yielded a Bayesian score of +6 to +9, supporting classification of the variant as likely pathogenic. This case illustrates refined variant interpretation within the ClinGen Bayesian framework through reassessment and integration of new evidence.

Read PDF

Similar papers

Case report Open access Oct 2026

Phenotypic Evidence for the Reclassification of the RYR1 p.(Glu4410Asp) Variant: From Uncertain Significance to Likely Benign

A 27-year-old African American female with a personal history of recurrent exertional rhabdomyolysis found to have a heterozygous RYR1 c.13230G>C p.(Glu4410Asp) variant is reported, which meets the ClinGen MHS Variant Curation Expert Panel (VCEP) criteria for reclassification of the variant to Likely Benign.

Isabella Mullally, Eugene Smith, Péter Bedőcs et al. · 0 citations
Open access Sep 2026

Functional Validation of a CC2D2A Non-Canonical Splice-Site Variant Supports Prenatal Molecular Testing in Joubert Syndrome

Background: Joubert syndrome (JS) is a genetically heterogeneous ciliopathy wherein non-canonical splice-site (NCSS) variants are frequently reported as variants of uncertain significance (VUS), complicating prenatal counseling. We aimed to clarify the clinical significance of an NCSS in CC2D2A through functional valid...

Fang Wang, J. Zhang, Chao Lu et al. · 0 citations
Review Open access Nov 2026

Bridging genotype and clinical phenotype: a multi-evidence framework for KCNMA1 variant interpretation

Patient-associated KCNMA1 variants are associated with a range of neurological disorders and considerable phenotypic and genetic heterogeneity. The rare prevalence of the disorder, paucity of inherited variants or individuals sharing the same variant, lack of diagnostic standardization, and incomplete understan...

C. Jodarski, Alexandra L. Shomali, Jenna R. M. Harvey et al. · 0 citations
Open access Nov 2026

Systematic overestimation using in silico-driven curation in a population database caused reevaluation of the genetic prevalence of Alport Syndrome.

INTRODUCTION A landmark study by Gibson and coworkers in 2021 estimated that one in 106 individuals carry a predicted pathogenic COL4A3 or COL4A4 variant, suggesting autosomal dominant Alport syndrome is massively underdiagnosed. However, pathogenicity of all triple-helical Glycine substitutions was inferred using in s...

T. Robert, Laure Raymond, X. Vanhoye et al. · 0 citations
Review Open access Nov 2026

Systematic Reclassification of Variants of Uncertain Significance in a Clinical Nephrogenomics Program: Insights from the RAPIDS Collaboration

A structured, multidisciplinary VUS resolution workflow enabled considerable VUS reclassification, nearly doubling the diagnostic yield and improvements in diagnostic yield and clinical utility.

Tung-Lin Lee, Yao-Chun Zhang, Tina Si Ting Lim et al. · 0 citations
Open access Oct 2026

The risk of over-interpreting in silico predictions as clinical evidence: a comment on Roy et al. (2024)

Concerns are highlighted: the lack of independence among some prediction tools used for variant prioritization; the interpretation of somatic mutation clustering as evidence for germline disease association; and the presentation of variants with no established clinical or experimental evidence as disease-associated.

D. Tchernitchko · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.